{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:46:35Z","timestamp":1785379595961,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although delayed cerebral vasospasm (DCV) following subarachnoid hemorrhage (SAH) is closely related to the progression of brain damage, little is known about the molecular mechanism underlying its development. High mobility group box-1 (HMGB1) plays an important role as an initial inflammatory mediator in SAH. In this study, an SAH rat model was employed to evaluate the effects of anti-HMGB1 monoclonal antibody (mAb) on DCV after SAH. A vasoconstriction of the basilar artery (BA) associated with a reduction of nuclear HMGB1 and its translocation in vascular smooth muscle cells were observed in SAH rats, and anti-HMGB1 mAb administration significantly suppressed these effects. Up-regulations of inflammation-related molecules and vasoconstriction-mediating receptors in the BA of SAH rats were inhibited by anti-HMGB1 mAb treatment. Anti-HMGB1 mAb attenuated the enhanced vasocontractile response to thrombin of the isolated BA from SAH rats and prevented activation of cerebrocortical microglia. Moreover, locomotor activity and weight loss recovery were also enhanced by anti-HMGB1 mAb administration. The vasocontractile response of the BA under SAH may be induced by events that are downstream of responses to HMGB1-induced inflammation and inhibited by anti-HMGB1 mAb. Anti-HMGB1 mAb treatment may provide a novel therapeutic strategy for DCV and early brain injury after SAH.<\/jats:p>","DOI":"10.1038\/srep37755","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T11:04:26Z","timestamp":1479985466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats"],"prefix":"10.1038","volume":"6","author":[{"given":"Jun","family":"Haruma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Teshigawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohito","family":"Hishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dengli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenori","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo Kohka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"BFsrep37755_CR1","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1161\/01.STR.16.4.562","volume":"16","author":"NF Kassell","year":"1985","unstructured":"Kassell, N. F., Sasaki, T., Colohan, A. R. & Nazar, G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 16, 562\u2013572 (1985).","journal-title":"Stroke"},{"key":"BFsrep37755_CR2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1179\/174313209X382395","volume":"31","author":"A Alaraj","year":"2009","unstructured":"Alaraj, A., Charbel, F. T. & Amin-Hanjani, S. Peri-operative measures for treatment and prevention of cerebral vasospasm following subarachnoid hemorrhage. Neurol Res 31, 651\u2013659 (2009).","journal-title":"Neurol Res"},{"key":"BFsrep37755_CR3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2007.07.059","volume":"1173","author":"ML Zhou","year":"2007","unstructured":"Zhou, M. L. et al. Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res 1173, 110\u2013116 (2007).","journal-title":"Brain Res"},{"key":"BFsrep37755_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00011-006-6035-9","volume":"56","author":"ML Zhou","year":"2007","unstructured":"Zhou, M. L. et al. Expression of Toll-like receptor 4 in the brain in a rabbit experimental subarachnoid haemorrhage model. Inflamm Res 56, 93\u201397 (2007).","journal-title":"Inflamm Res"},{"key":"BFsrep37755_CR5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2011.03.006","volume":"305","author":"Y Wu","year":"2011","unstructured":"Wu, Y. et al. Therapeutic potential of peroxisome proliferator-activated receptor gamma agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model. J Neurol Sci 305, 85\u201391 (2011).","journal-title":"J Neurol Sci"},{"key":"BFsrep37755_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.brainres.2013.05.010","volume":"1520","author":"Q Sun","year":"2013","unstructured":"Sun, Q. et al. Expression and cell distribution of myeloid differentiation primary response protein 88 in the cerebral cortex following experimental subarachnoid hemorrhage in rats: a pilot study. Brain Res 1520, 134\u2013144 (2013).","journal-title":"Brain Res"},{"key":"BFsrep37755_CR7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11011-014-9609-1","volume":"30","author":"Z Li","year":"2015","unstructured":"Li, Z. et al. Blood-brain barrier permeability change and regulation mechanism after subarachnoid hemorrhage. Metab Brain Dis 30, 597\u2013603 (2015).","journal-title":"Metab Brain Dis"},{"key":"BFsrep37755_CR8","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/sj.jcbfm.9600456","volume":"27","author":"ML Zhou","year":"2007","unstructured":"Zhou, M. L. et al. Potential contribution of nuclear factor-kappaB to cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. J Cereb Blood Flow Metab 27, 1583\u20131592 (2007).","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFsrep37755_CR9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.STR.32.1.225","volume":"32","author":"M Satoh","year":"2001","unstructured":"Satoh, M. et al. Inhibition of poly (ADP-ribose) polymerase attenuates cerebral vasospasm after subarachnoid hemorrhage in rabbits. Stroke 32, 225\u2013231 (2001).","journal-title":"Stroke"},{"key":"BFsrep37755_CR10","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3171\/jns.2002.96.6.1094","volume":"96","author":"S Ono","year":"2002","unstructured":"Ono, S., Komuro, T. & Macdonald, R. L. Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 96, 1094\u20131102 (2002).","journal-title":"J Neurosurg"},{"key":"BFsrep37755_CR11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1227\/01.NEU.0000363153.62579.FF","volume":"66","author":"M Nishiguchi","year":"2010","unstructured":"Nishiguchi, M. et al. Effect of vasodilation by milrinone, a phosphodiesterase III inhibitor, on vasospastic arteries after a subarachnoid hemorrhage in vitro and in vivo: effectiveness of cisternal injection of milrinone. Neurosurgery 66, 158\u2013164, discussion 164 (2010).","journal-title":"Neurosurgery"},{"key":"BFsrep37755_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3171\/JNS-07\/07\/0128","volume":"107","author":"K Iseda","year":"2007","unstructured":"Iseda, K. et al. Antivasospastic and antiinflammatory effects of caspase inhibitor in experimental subarachnoid hemorrhage. J Neurosurg 107, 128\u2013135 (2007).","journal-title":"J Neurosurg"},{"key":"BFsrep37755_CR13","first-page":"823","volume":"5","author":"AD Greenhalgh","year":"2012","unstructured":"Greenhalgh, A. D. et al. Interleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathology. Dis Model Mech 5, 823\u2013833 (2012).","journal-title":"Dis Model Mech"},{"key":"BFsrep37755_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nri1594","volume":"5","author":"MT Lotze","year":"2005","unstructured":"Lotze, M. T. & Tracey, K. J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5, 331\u2013342 (2005).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep37755_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson, U. & Tracey, K. J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29, 139\u2013162 (2011).","journal-title":"Annu Rev Immunol"},{"key":"BFsrep37755_CR16","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1523\/JNEUROSCI.2435-08.2008","volume":"28","author":"S Muhammad","year":"2008","unstructured":"Muhammad, S. et al. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 28, 12023\u201312031 (2008).","journal-title":"J Neurosci"},{"key":"BFsrep37755_CR17","doi-asserted-by":"crossref","first-page":"25752","DOI":"10.1074\/jbc.270.43.25752","volume":"270","author":"O Hori","year":"1995","unstructured":"Hori, O. et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 270, 25752\u201325761 (1995).","journal-title":"J Biol Chem"},{"key":"BFsrep37755_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10456-008-9093-5","volume":"11","author":"JR van Beijnum","year":"2008","unstructured":"van Beijnum, J. R., Buurman, W. A. & Griffioen, A. W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11, 91\u201399 (2008).","journal-title":"Angiogenesis"},{"key":"BFsrep37755_CR19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/STROKEAHA.110.598334","volume":"42","author":"J Zhang","year":"2011","unstructured":"Zhang, J. et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42, 1420\u20131428 (2011).","journal-title":"Stroke"},{"key":"BFsrep37755_CR20","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.23602","volume":"72","author":"Y Okuma","year":"2012","unstructured":"Okuma, Y. et al. Anti-high mobility group box-1 antibody therapy for traumatic brain injury. Ann Neurol 72, 373\u2013384 (2012).","journal-title":"Ann Neurol"},{"key":"BFsrep37755_CR21","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1096\/fj.07-8770com","volume":"21","author":"K Liu","year":"2007","unstructured":"Liu, K. et al. Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. Faseb j 21, 3904\u20133916 (2007).","journal-title":"Faseb j"},{"key":"BFsrep37755_CR22","first-page":"194","volume":"9","author":"XD Zhu","year":"2012","unstructured":"Zhu, X. D. et al. Relationship between plasma high mobility group box-1 protein levels and clinical outcomes of aneurysmal subarachnoid hemorrhage. J Neuroinflammation 9, 194 (2012).","journal-title":"J Neuroinflammation"},{"key":"BFsrep37755_CR23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12028-009-9276-y","volume":"11","author":"T Nakahara","year":"2009","unstructured":"Nakahara, T. et al. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage. Neurocrit Care 11, 362\u2013368 (2009).","journal-title":"Neurocrit Care"},{"key":"BFsrep37755_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12975-010-0052-2","volume":"2","author":"K Murakami","year":"2011","unstructured":"Murakami, K. et al. Subarachnoid Hemorrhage Induces Gliosis and Increased Expression of the Pro-inflammatory Cytokine High Mobility Group Box 1 Protein. Transl Stroke Res 2, 72\u201379 (2011).","journal-title":"Transl Stroke Res"},{"key":"BFsrep37755_CR25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1748-1716.2007.01724.x","volume":"191","author":"PB Hansen","year":"2007","unstructured":"Hansen, P. B., Friis, U. G., Uhrenholt, T. R., Briggs, J. & Schnermann, J. Intracellular signalling pathways in the vasoconstrictor response of mouse afferent arterioles to adenosine. Acta Physiol (Oxf) 191, 89\u201397 (2007).","journal-title":"Acta Physiol (Oxf)"},{"key":"BFsrep37755_CR26","first-page":"628597","volume":"2014","author":"G Cossu","year":"2014","unstructured":"Cossu, G., Messerer, M., Oddo, M. & Daniel, R. T. To look beyond vasospasm in aneurysmal subarachnoid haemorrhage. Biomed Res Int 2014, 628597 (2014).","journal-title":"Biomed Res Int"},{"key":"BFsrep37755_CR27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald, R. L. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 10, 44\u201358 (2014).","journal-title":"Nat Rev Neurol"},{"key":"BFsrep37755_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3171\/2013.3.JNS121436","volume":"119","author":"J Shen","year":"2013","unstructured":"Shen, J., Pan, J. W., Fan, Z. X., Xiong, X. X. & Zhan, R. Y. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials. J Neurosurg 119, 180\u2013189 (2013).","journal-title":"J Neurosurg"},{"key":"BFsrep37755_CR29","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1161\/STROKEAHA.112.666693","volume":"43","author":"MD Vergouwen","year":"2012","unstructured":"Vergouwen, M. D., Algra, A. & Rinkel, G. J. Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update. Stroke 43, 2671\u20132676 (2012).","journal-title":"Stroke"},{"key":"BFsrep37755_CR30","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1227\/00006123-199507000-00041","volume":"37","author":"JM Findlay","year":"1995","unstructured":"Findlay, J. M. et al. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37, 168\u2013176, discussion 177\u2013168 (1995).","journal-title":"Neurosurgery"},{"key":"BFsrep37755_CR31","first-page":"509707","volume":"2014","author":"M Eisenhut","year":"2014","unstructured":"Eisenhut, M. Vasospasm in cerebral inflammation. Int J Inflam 2014, 509707 (2014).","journal-title":"Int J Inflam"},{"key":"BFsrep37755_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.nec.2009.10.008","volume":"21","author":"G Pradilla","year":"2010","unstructured":"Pradilla, G., Chaichana, K. L., Hoang, S., Huang, J. & Tamargo, R. J. Inflammation and cerebral vasospasm after subarachnoid hemorrhage. Neurosurg Clin N Am 21, 365\u2013379 (2010).","journal-title":"Neurosurg Clin N Am"},{"key":"BFsrep37755_CR33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/00004647-200107000-00013","volume":"21","author":"K Nakamura","year":"2001","unstructured":"Nakamura, K. et al. Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase. J Cereb Blood Flow Metab 21, 876\u2013885 (2001).","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFsrep37755_CR34","first-page":"1575","volume":"122","author":"CX Ma","year":"2009","unstructured":"Ma, C. X. et al. Toll-like receptor 4\/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl) 122, 1575\u20131581 (2009).","journal-title":"Chin Med J (Engl)"},{"key":"BFsrep37755_CR35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1136\/jnnp-2012-304635","volume":"84","author":"MJ Pyysalo","year":"2013","unstructured":"Pyysalo, M. J., Pyysalo, L. M., Pessi, T., Karhunen, P. J. & Ohman, J. E. The connection between ruptured cerebral aneurysms and odontogenic bacteria. J Neurol Neurosurg Psychiatry 84, 1214\u20131218 (2013).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFsrep37755_CR36","doi-asserted-by":"crossref","unstructured":"Li, H. et al. Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage. Mol Neurobiol, doi: 10.1007\/s12035-016-9703-y (2016).","DOI":"10.1007\/s12035-016-9703-y"},{"key":"BFsrep37755_CR37","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1007\/s11064-016-1863-7","volume":"41","author":"G Hao","year":"2016","unstructured":"Hao, G. et al. Rutin Inhibits Neuroinflammation and Provides Neuroprotection in an Experimental Rat Model of Subarachnoid Hemorrhage, Possibly Through Suppressing the RAGE-NF-kappaB Inflammatory Signaling Pathway. Neurochem Res 41, 1496\u20131504 (2016).","journal-title":"Neurochem Res"},{"key":"BFsrep37755_CR38","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1161\/STROKEAHA.107.487769","volume":"38","author":"Y Kai","year":"2007","unstructured":"Kai, Y. et al. Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke 38, 3259\u20133265 (2007).","journal-title":"Stroke"},{"key":"BFsrep37755_CR39","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bjp.0707435","volume":"152","author":"Y Maeda","year":"2007","unstructured":"Maeda, Y. et al. Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage. Br J Pharmacol 152, 1131\u20131139 (2007).","journal-title":"Br J Pharmacol"},{"key":"BFsrep37755_CR40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pneurobio.2012.02.003","volume":"97","author":"FA Sehba","year":"2012","unstructured":"Sehba, F. A., Hou, J., Pluta, R. M. & Zhang, J. H. The importance of early brain injury after subarachnoid hemorrhage. Prog Neurobiol 97, 14\u201337 (2012).","journal-title":"Prog Neurobiol"},{"key":"BFsrep37755_CR41","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/ATVBAHA.115.305789","volume":"35","author":"J Cai","year":"2015","unstructured":"Cai, J. et al. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4. Arterioscler Thromb Vasc Biol 35, 2579\u20132593 (2015).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep37755_CR42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12975-016-0466-6","volume":"7","author":"A Munakata","year":"2016","unstructured":"Munakata, A., Naraoka, M., Katagai, T., Shimamura, N. & Ohkuma, H. Role of Cyclooxygenase-2 in Relation to Nitric Oxide and Endothelin-1 on Pathogenesis of Cerebral Vasospasm After Subarachnoid Hemorrhage in Rabbit. Transl Stroke Res 7, 220\u2013227 (2016).","journal-title":"Transl Stroke Res"},{"key":"BFsrep37755_CR43","doi-asserted-by":"crossref","first-page":"H2551","DOI":"10.1152\/ajpheart.00616.2002","volume":"283","author":"I Gules","year":"2002","unstructured":"Gules, I., Satoh, M., Clower, B. R., Nanda, A. & Zhang, J. H. Comparison of three rat models of cerebral vasospasm. Am J Physiol Heart Circ Physiol 283, H2551\u20132559 (2002).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep37755_CR44","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/STROKEAHA.108.521740","volume":"40","author":"SJ Schambach","year":"2009","unstructured":"Schambach, S. J. et al. Ultrafast high-resolution in vivo volume-CTA of mice cerebral vessels. Stroke 40, 1444\u20131450 (2009).","journal-title":"Stroke"},{"key":"BFsrep37755_CR45","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3174\/ajnr.A2586","volume":"32","author":"R Gupta","year":"2011","unstructured":"Gupta, R. et al. Temporal resolution of dynamic angiography using flat panel volume CT: in vivo evaluation of time-dependent vascular pathologies. AJNR Am J Neuroradiol 32, 1688\u20131696 (2011).","journal-title":"AJNR Am J Neuroradiol"},{"key":"BFsrep37755_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00062-011-0113-2","volume":"22","author":"G Figueiredo","year":"2012","unstructured":"Figueiredo, G. et al. Comparison of digital subtraction angiography, micro-computed tomography angiography and magnetic resonance angiography in the assessment of the cerebrovascular system in live mice. Clin Neuroradiol 22, 21\u201328 (2012).","journal-title":"Clin Neuroradiol"},{"key":"BFsrep37755_CR47","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.tranon.2014.02.016","volume":"7","author":"J Ishida","year":"2014","unstructured":"Ishida, J. et al. Integrin inhibitor suppresses bevacizumab-induced glioma invasion. Transl Oncol 7, 292\u2013302.e291 (2014).","journal-title":"Transl Oncol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep37755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37755","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep37755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T01:05:22Z","timestamp":1672880722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep37755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep37755"],"URL":"https:\/\/doi.org\/10.1038\/srep37755","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]},"assertion":[{"value":"18 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37755"}}